Aarti Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

559.53

538.21

577.54

591.63

696.41

Operating profit

69.06

59.74

65.42

71.90

88.52

Interest

8.09

6.75

7.55

7.77

8.35

Gross profit

62.08

54.67

58.61

64.79

81.10

EPS (Rs)

3.93

3.44

3.76

4.27

5.74

Other income

1.11

1.68

0.74

0.66

0.93

Stock adjustment

14.50

28.17

-8.62

-7.28

44.67

Raw material

345.65

329.93

391.97

399.02

435.39

Power and fuel

-

-

-

-

-

Employee expenses

19.94

20.24

20.04

20.66

21.10

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

110.38

100.13

108.73

107.33

106.73

Provisions made

-

-

-

-

-

Depreciation

12.34

11.80

11.78

11.75

11.68

Taxation

13.60

11.25

12.25

13.50

16.25

Net profit / loss

36.14

31.62

34.58

39.54

53.17

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

91.94

91.94

91.94

92.60

92.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.34

11.10

11.33

12.15

12.71

GPM (%)

11.07

10.13

10.14

10.94

11.63

NPM (%)

6.45

5.86

5.98

6.68

7.62